Oramed Pharm (OJU1) Financial Statements
Oramed Pharm Financial Overview
Oramed Pharm's market cap is currently $152.57M. The company's EPS TTM is $4.23; its P/E ratio is 0.97; Oramed Pharm is scheduled to report earnings on April 10, 2023, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Sep 23 | Dec 22 | Aug 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.00M | $ 0.00 | $ 1.34M | $ 2.70M | $ 2.70M |
| Gross Profit | $ 13.00K | $ 0.00 | $ 1.34M | $ 2.70M | $ 2.70M |
| Operating Income | $ -15.09M | $ -12.78M | $ -15.77M | $ -40.60M | $ -24.22M |
| EBITDA | $ 75.44M | $ -14.87M | $ 7.32M | $ -40.54M | $ -24.15M |
| Net Income | $ 64.05M | $ -19.06M | $ 5.53M | $ -37.76M | $ -22.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 125.89M | $ 141.93M | $ 162.05M | $ 155.72M | $ 94.14M |
| Total Assets | $ 230.86M | $ 155.28M | $ 220.55M | $ 161.64M | $ 128.00M |
| Total Debt | $ 825.00K | $ 372.00K | $ 51.62M | $ 894.00K | $ 533.00K |
| Net Debt | $ -45.12M | $ -54.05M | $ 42.57M | $ -39.57M | $ -76.71M |
| Total Liabilities | $ 31.12M | $ 9.93M | $ 57.66M | $ 10.49M | $ 11.48M |
| Stockholders' Equity | $ 199.74M | $ 146.26M | $ 163.82M | $ 151.81M | $ 115.77M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.08M | $ -8.43M | $ -10.55M | $ -29.20M | $ -21.56M |
| Operating Cash Flow | $ -9.14M | $ -8.41M | $ -10.29M | $ -28.70M | $ -21.18M |
| Investing Cash Flow | $ 5.44M | $ 105.82M | $ -73.04M | $ 30.21M | $ -22.26M |
| Financing Cash Flow | $ -4.74M | $ -52.04M | $ 51.98M | $ 11.56M | $ 101.39M |
Currency in USD